23 February 2022>: Clinical Research
A Retrospective Study of the Safety and Efficacy of Endoscopic Radiofrequency Therapy Under Direct Vision in 59 Patients with Gastroesophageal Reflux Disease from 2 Centers in Beijing, China Using the Gastroesophageal Reflux Disease Questionnaire
Di Lu 1ABCDEFG* , Chun Shan Bi 2ABCE* , Xue Wei 1BCDEF* , Bao Na Guo 2BC , Ying Xin Gao 1BG , Jing Chen 2B , Jie Qian 1BG , Zi Hao Guo 2B , Yan Bin Wang 1B , Li Li 2B , Chuan Zhang 2A* , Jian Yu Hao 1AG* , Yan Gao 1ABD*DOI: 10.12659/MSM.933848
Med Sci Monit 2022; 28:e933848
Table 3 Comparison of PPIs* usage reduction between the 2 groups.
Timing of RF** | Direct vision (N=27) | Non-direct vision (N=29) | P value |
---|---|---|---|
Before RF** | 0 (0) | 0 (0) | – |
3 months after RF** | 22 (81.5%) | 22 (75.9%) | 0.609 |
6 months after RF** | 24 (88.9%) | 28 (96.6%) | 0.343 |
12 months after RF (N=45)** | 20 (95.2%) (N=21) | 23 (95.8%) (N=24) | 1.000 |
* PPIs denotes proton pump inhibitors; ** RF denotes radiofrequency. |